|
⚲
|
| Keyboard |
| Michael Mendelsohn | |
|---|---|
| Firm | |
| Address | c/o Cardurion Pharmaceuticals, Inc 78 Blanchard Road, Suite 200 Burlington, MA 01803 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cardurion Pharmaceuticals Inc | 021-519629 | Executive Officer | 260.4 M of 260.4 M |
||
| Cardurion Pharmaceuticals Inc | 021-469288 | Executive Officer | 17.5 M of 17.5 M |
||
| Cardurion Pharmaceuticals Inc | 021-419648 | Executive Officer | 128.1 M of 128.1 M |
||
| Cyclerion Therapeutics Inc | 021-403393 | Director | 18.0 M of 18.0 M |
||
| Cyclerion Therapeutics Inc | 021-372991 | Director | 24.2 M of 24.2 M |
||
| Cardurion Pharmaceuticals Inc | 021-353793 | Executive Officer | 10.0 M of 10.0 M |
||
| Cyclerion Therapeutics Inc | 021-337559 | Director | 175.0 M of 175.0 M |
||
| Cardurion Pharmaceuticals LLC | 021-283999 | Executive Officer | 15.7 M of 22.4 M |
||
| Regado Biosciences Inc | 021-212433 | Director | 20.0 M of 20.0 M |
||